NLS Pharmaceutics AG
NNASDAQ:NLSPW- -
USD
- -
- -
Financial Position
As of June 30, 2025, NLS Pharmaceutics AG maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | -16.89 |
Scores
As of June 30, 2025, NLS Pharmaceutics AG has an Altman Z-Score of -322.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -322.91 |